Abstract:Background: Heparinase I from Pedobacter heparinus (Ph-HepI), which specifically cleaves heparin and heparan sulfate, is one of the most extensively studied glycosaminoglycan lyases. Enzymatic degradation of heparin by heparin lyases not only largely facilitates heparin structural analysis but also showed great potential to produce low-molecular-weight heparin (LMWH) in an environmentally friendly way. However, industrial applications of Ph-HepI have been limited by their poor yield and enzyme activity. In this work, we improve the specific enzyme activity of Ph-HepI based on homology modeling, multiple sequence alignment, molecular docking and site-directed mutagenesis. Results: Three mutations (S169D, A259D, S169D/A259D) exhibited a 50.18, 40.43, and 122.05% increase in the specific enzyme activity and a 91.67, 108.33, and 75% increase in the yield, respectively. The catalytic efficiencies (kcat/Km) of the mutanted enzymes S169D, A259D, and S169D/A259D were higher than those of the wild-type enzyme by 275, 164, and 406%, respectively. Mass spectrometry and activity detection showed the enzyme degradation products were in line with the standards of the European Pharmacopoeia. Protein structure analysis showed that hydrogen bonds and ionic bonds were important factors for improving specific enzyme activity and yield. Conclusions: We found that the mutant S169D/A259D had more industrial application value than the wild-type enzyme due to molecular modifications. Our results provide a new strategy to increase the catalytic efficiency of other heparinases.

Optimization of Heparinase Production by Flavobacterium Heparinum

High-Level Expression and Purification of Recombinant Heparinase Ⅰ in Escherichia Coli

Optimization of Cultivation Conditions of Recombinant E.coli for Production of Soluble MBP-fused Heparinase I

Combination of Site-Directed Mutagenesis and Calcium Ion Addition for Enhanced Production of Thermostable MBP-fused Heparinase I in Recombinant Escherichia Coli

Production of MBP–HepA Fusion Protein in Recombinant Escherichia Coli by Optimization of Culture Medium

Clonging and Expression of Heparinase III Gene from Flavobacterium heparinum and Characterization of the Recombinant Fusion Enzyme

Optimization of Fermentation Conditions for the Production of Neutral Protease by Bacillus Subtilis

Optimization of Fermentation Parameters for beta-Glucosidase Production by Aspergillus niger

Progress in the Study of Heparinases

Studies on the Fermentation Condition Optimization of Fibrinolytic Enzyme Produced by Armiilaria Luteo-virens Sacc

Optimization of Culture Conditions for Production of Cis-Epoxysuccinic Acid Hydrolase Using Response Surface Methodology

Optimization of Fermentation for Production Conditions of Antibiotic by Bacillus amyloliquefaciens D1

Production of Heparin Oligosaccharides by Fusion Protein of MBP–heparinase I and the Enzyme Thermostability

Construction Of Engineered E-Coli System For The Overproduction Of Soluble Heparinase I

Structure-based engineering of heparinase I with improved specific activity for degrading heparin

Construction of recombinant for over-production of soluble heparinase I by fusion to maltose-binding protein

Improved Keratinase Production for Feather Degradation by Bacillus Licheniformis Zjuel31410 in Submerged Cultivation

Optimization of Fermentation Medium for Production of Antibacterial Peptides by Bacillus Subtilis BSD-2

Immobilized high-performance heparin lyase III for efficient preparation of low molecular weight heparin

E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor

Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies